161 related articles for article (PubMed ID: 9204983)
1. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?
Pawson R; Matutes E; Brito-Babapulle V; Maljaie H; Hedges M; Mercieca J; Dyer M; Catovsky D
Leukemia; 1997 Jul; 11(7):1009-13. PubMed ID: 9204983
[TBL] [Abstract][Full Text] [Related]
2. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
Dybjer A; Hellquist L; Johansson B; Rydgren L; Billström R
Leuk Lymphoma; 2000 Apr; 37(3-4):437-40. PubMed ID: 10752996
[TBL] [Abstract][Full Text] [Related]
3. Sezary cell-like leukemia: a distinct type of mature T cell malignancy.
Matutes E; Keeling DM; Newland AC; Scott CS; Mitchell D; Traub N; Wardle DG; Catovsky D
Leukemia; 1990 Apr; 4(4):262-6. PubMed ID: 2366582
[TBL] [Abstract][Full Text] [Related]
4. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
Foucar K
Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
[TBL] [Abstract][Full Text] [Related]
5. [The clinical and laboratory characteristics of mature (postthymic) T-cell malignant neoplasms].
Matutes E; Catovsky D
Gematol Transfuziol; 1993 May; 38(5):3-6. PubMed ID: 8034169
[No Abstract] [Full Text] [Related]
6. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization.
Brito-Babapulle V; Maljaie SH; Matutes E; Hedges M; Yuille M; Catovsky D
Br J Haematol; 1997 Mar; 96(4):724-32. PubMed ID: 9074412
[TBL] [Abstract][Full Text] [Related]
7. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
[No Abstract] [Full Text] [Related]
8. T-cell chronic lymphocytic leukaemia: the spectrum of mature T-cell disorders.
Matutes E; Brito-Babapulle V; Worner I; Sainati L; Foroni L; Catovsky D
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):347-51. PubMed ID: 3265506
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphoproliferative disorders: classification and diagnosis.
Litz CE; Brunning RD
Baillieres Clin Haematol; 1993 Dec; 6(4):767-83. PubMed ID: 8038489
[TBL] [Abstract][Full Text] [Related]
11. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.
Brito-Babapulle V; Hamoudi R; Matutes E; Watson S; Kaczmarek P; Maljaie H; Catovsky D
Br J Haematol; 2000 Jul; 110(1):180-7. PubMed ID: 10930996
[TBL] [Abstract][Full Text] [Related]
12. [Unclassified mature T cell leukemia with cerebriform nuclei].
Takizawa M; Matsushima T; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2005 Jul; 46(7):486-91. PubMed ID: 16440739
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
14. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
Garand R; Goasguen J; Brizard A; Buisine J; Charpentier A; Claisse JF; Duchayne E; Lagrange M; Segonds C; Troussard X; Flandrin G
Br J Haematol; 1998 Nov; 103(2):488-94. PubMed ID: 9827924
[TBL] [Abstract][Full Text] [Related]
15. Deoxycoformycin in the treatment of mature T-cell leukaemias.
Dearden C; Matutes E; Catovsky D
Br J Cancer; 1991 Nov; 64(5):903-6. PubMed ID: 1931613
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous infiltration in T-cell prolymphocytic leukaemia.
Mallett RB; Matutes E; Catovsky D; Maclennan K; Mortimer PS; Holden CA
Br J Dermatol; 1995 Feb; 132(2):263-6. PubMed ID: 7888364
[TBL] [Abstract][Full Text] [Related]
17. Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T-prolymphocytic leukaemia: four new cases and a review of the literature.
Mossafa H; Brizard A; Huret JL; Brizard F; Lessard M; Guilhot F; Tanzer J
Br J Haematol; 1994 Apr; 86(4):780-5. PubMed ID: 7918072
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia.
Tuset E; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
Leuk Lymphoma; 2001; 42(6):1379-83. PubMed ID: 11911422
[TBL] [Abstract][Full Text] [Related]
19. Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis.
Matutes E; Coelho E; Aguado MJ; Morilla R; Crawford A; Owusu-Ankomah K; Catovsky D
J Clin Pathol; 1996 Feb; 49(2):154-8. PubMed ID: 8655683
[TBL] [Abstract][Full Text] [Related]
20. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
